JP5095463B2 - Biological information measuring device - Google Patents

Biological information measuring device Download PDF

Info

Publication number
JP5095463B2
JP5095463B2 JP2008081216A JP2008081216A JP5095463B2 JP 5095463 B2 JP5095463 B2 JP 5095463B2 JP 2008081216 A JP2008081216 A JP 2008081216A JP 2008081216 A JP2008081216 A JP 2008081216A JP 5095463 B2 JP5095463 B2 JP 5095463B2
Authority
JP
Japan
Prior art keywords
blood pressure
cuff
measurement
pulse wave
calcification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2008081216A
Other languages
Japanese (ja)
Other versions
JP2009233003A (en
Inventor
智幸 山本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fukuda Denshi Co Ltd
Original Assignee
Fukuda Denshi Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fukuda Denshi Co Ltd filed Critical Fukuda Denshi Co Ltd
Priority to JP2008081216A priority Critical patent/JP5095463B2/en
Publication of JP2009233003A publication Critical patent/JP2009233003A/en
Application granted granted Critical
Publication of JP5095463B2 publication Critical patent/JP5095463B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Description

本発明は、生体情報測定装置に関し、特に、オシロメトリック式の血圧測定が可能な生体情報測定装置に関する。   The present invention relates to a biological information measuring device, and more particularly to a biological information measuring device capable of oscillometric blood pressure measurement.

オシロメトリック式の血圧測定は、一般的な血圧測定手法の一つであり、被検者の血圧検査のみならず、被検者の動脈硬化度の検査等にも利用されている。この血圧測定手法では、被検者の腕或いは脚に巻回したカフにより血管を圧迫し、そのときに検出される脈波振幅及びカフ圧(カフ内部の気圧)に基づいて被検者の血圧を判定する。   The oscillometric blood pressure measurement is one of the general blood pressure measurement techniques, and is used not only for the blood pressure examination of the subject but also for the examination of the degree of arteriosclerosis of the subject. In this blood pressure measurement method, a blood vessel is compressed by a cuff wound around the arm or leg of the subject, and the blood pressure of the subject is determined based on the pulse wave amplitude and the cuff pressure (atmospheric pressure inside the cuff) detected at that time. Determine.

カフ減圧中(すなわちカフからの排気中)の脈波振幅及びカフ圧に基づいて血圧判定を行う血圧計(例えば特許文献1参照)では、脈波の振幅が増大する過程で最高血圧が判定され、脈波の振幅が減少する過程で最低血圧が判定される。また、カフ加圧中(すなわちカフへの給気中)の脈波振幅及びカフ圧に基づいて血圧判定を行う血圧計(例えば特許文献2参照)では、脈波の振幅が増大する過程で最低血圧が判定され、脈波の振幅が減少する過程で最高血圧が判定される。
特開2006−75437号公報 特開2001−204698号公報
In a sphygmomanometer that performs blood pressure determination based on the pulse wave amplitude and cuff pressure during cuff decompression (ie, during exhaust from the cuff) (see, for example, Patent Document 1), the maximum blood pressure is determined in the process of increasing the amplitude of the pulse wave. The diastolic blood pressure is determined in the process of decreasing the amplitude of the pulse wave. Further, in a sphygmomanometer (for example, see Patent Document 2) that performs blood pressure determination based on the pulse wave amplitude and the cuff pressure during cuff pressurization (that is, during air supply to the cuff), the lowest is the process in which the pulse wave amplitude increases. The blood pressure is determined, and the systolic blood pressure is determined in the process in which the pulse wave amplitude decreases.
JP 2006-75437 A JP 2001-204698 A

ところで、被検者によっては、測定部位の血管が例えば石灰化により硬化した状態となっている場合もある。この場合、血管の弾性変形が生じにくくなる。よって、オシロメトリック式の血圧測定では、血管の狭窄や閉塞を生じさせるのに必要なカフ圧が高くなるため、測定血圧の値が実際の血圧の値よりも高くなる傾向がある。   By the way, depending on the subject, the blood vessel at the measurement site may be hardened due to, for example, calcification. In this case, elastic deformation of the blood vessel is difficult to occur. Therefore, in the oscillometric blood pressure measurement, the cuff pressure required to cause stenosis or occlusion of the blood vessel increases, and therefore the measured blood pressure value tends to be higher than the actual blood pressure value.

しかしながら、オシロメトリック式の血圧測定を行う上記従来の血圧計においては、血管石灰化の有無を判定することができないため、血管石灰化の発症の有無に応じて適切な測定結果を出力することができず、したがって、血管石灰化の発症者に対する使用に適していないという問題がある。   However, in the above-described conventional sphygmomanometer that performs oscillometric blood pressure measurement, it is not possible to determine the presence or absence of vascular calcification. There is a problem that it is not possible and therefore not suitable for use against those who develop vascular calcification.

本発明は、かかる点に鑑みてなされたもので、血管石灰化の発症者に対する使用に適した生体情報測定装置を提供することを目的とする。   This invention is made | formed in view of this point, and it aims at providing the biometric information measuring apparatus suitable for the use with respect to the onset person of vascular calcification.

本発明の生体情報測定装置は、カフ圧の加圧中及び減圧中に血圧を測定する測定部と、前記カフ圧の加圧中及び減圧中に測定した前記血圧の値の差を判定する判定部と、判定の結果、前記差がある場合に、血管石灰化の可能性がある旨の情報を表示する表示部とを有する構成を採る。   The biological information measuring apparatus according to the present invention is configured to determine a difference between a measurement unit that measures blood pressure during pressurization and decompression of the cuff pressure, and a value of the blood pressure measured during pressurization and decompression of the cuff pressure. And a display unit that displays information indicating the possibility of blood vessel calcification when there is the difference as a result of the determination.

本発明によれば、血管石灰化の発症者に対する使用に適した生体情報測定結果を提供することができる。   ADVANTAGE OF THE INVENTION According to this invention, the biometric information measurement result suitable for the use with respect to the onset person of vascular calcification can be provided.

以下、本発明の実施の形態について、図面を用いて詳細に説明する。   Hereinafter, embodiments of the present invention will be described in detail with reference to the drawings.

図1は、本発明の一実施の形態に係る血圧脈波検査装置の構成を示す図である。   FIG. 1 is a diagram showing a configuration of a blood pressure pulse wave inspection apparatus according to an embodiment of the present invention.

図1の血圧脈波検査装置は、装置本体において、演算制御部10、血圧脈波計測部20、心音計測部30、心電図計測部40、脈波計測部50、表示部70、記録部75、保存部80、音声発生部85及び操作部90を備えると共に、装置本体に、左腕用のカフ21a、右腕用のカフ21b、左脚用のカフ21c及び右脚用のカフ21dをそれぞれホース22a、22b、22c、22dを介して接続し、心音マイク31を接続し、四肢用の心電電極部41a及び胸部用の心電電極部41bを接続し、脈波センサ51a、51bを接続してなるものである。   The blood pressure pulse wave test apparatus in FIG. 1 includes an arithmetic control unit 10, a blood pressure pulse wave measurement unit 20, a heart sound measurement unit 30, an electrocardiogram measurement unit 40, a pulse wave measurement unit 50, a display unit 70, a recording unit 75, In addition to the storage unit 80, the sound generation unit 85, and the operation unit 90, the hose 22a, the cuff 21a for the left arm, the cuff 21b for the right arm, the cuff 21c for the left leg, and the cuff 21d for the right leg are respectively attached to the apparatus body. 22b, 22c, 22d, connected to the heart sound microphone 31, connected to the electrocardiogram electrode part 41a for the extremities and the electrocardiogram electrode part 41b for the chest, and connected to the pulse wave sensors 51a, 51b. Is.

演算制御部10は、演算処理装置と記憶装置とからなるものであり、記憶装置に予め記憶された制御プログラムを、操作部90からの入力信号に従って演算処理装置で実行することにより、以下説明する装置全体の動作を制御し、血圧脈波検査装置の各機能を実現させる。   The arithmetic control unit 10 includes an arithmetic processing device and a storage device, and will be described below by executing a control program stored in the storage device in advance according to an input signal from the operation unit 90. The operation of the entire apparatus is controlled to realize each function of the blood pressure pulse wave inspection apparatus.

演算制御部10は、各種生体情報の計測を行う血圧脈波計測部20、心音計測部30、心電図計測部40及び脈波計測部50(以下「生体情報計測部」と総称する)の計測実行タイミングを制御し、各生体情報計測部から生体情報の計測結果を示すディジタルデータ(生体データ)を受信する。演算制御部10は、受信した生体データを保存部80に読み出し可能なデータとして保存する。   The arithmetic control unit 10 executes measurement of a blood pressure pulse wave measurement unit 20, a heart sound measurement unit 30, an electrocardiogram measurement unit 40, and a pulse wave measurement unit 50 (hereinafter collectively referred to as “biological information measurement unit”) that measure various biological information. The timing is controlled, and digital data (biological data) indicating the measurement result of the biological information is received from each biological information measuring unit. The arithmetic control unit 10 stores the received biological data as readable data in the storage unit 80.

また、演算制御部10は、受信した生体データを、文字や波形等の視覚的な情報として表示部70又は記録部75に表示又は印刷させるために表示用データ又は印刷用データに変換し、表示用データ又は印刷用データを表示部70又は記録部75に出力する。なお、変換される生体データは、保存部80から読み出されたものであってもよい。   The arithmetic control unit 10 converts the received biometric data into display data or print data for display or printing on the display unit 70 or the recording unit 75 as visual information such as characters and waveforms. The data for printing or the data for printing is output to the display unit 70 or the recording unit 75. The biometric data to be converted may be read from the storage unit 80.

また、演算制御部10は、血圧脈波計測部20から、後述する血管石灰化判定データを、血圧データと共に受信した場合は、受信した血管石灰化判定データを、文字等の視覚的な情報として表示部70又は記録部75に表示又は印刷させるための表示用データ又は印刷用データに変換し、表示用データ又は印刷用データを表示部70又は記録部75に出力する。   Further, when the blood vessel calcification determination data, which will be described later, is received from the blood pressure pulse wave measurement unit 20 together with the blood pressure data, the arithmetic control unit 10 uses the received blood vessel calcification determination data as visual information such as characters. The data is converted into display data or print data to be displayed or printed on the display unit 70 or the recording unit 75, and the display data or print data is output to the display unit 70 or the recording unit 75.

また、演算制御部10は、受信し又は読み出した生体データに基づいて、又はこの生体データに対して特徴点検出等の波形分析を行い、波形分析の結果に基づいて、動脈硬化を評価するための指数(例えば、ABI(Ankle Brachial Index)、PWV(Pulse Wave Velocity)、CAVI(Cardio-Ankle Vascular Index)等)を算出する。演算制御部10は、波形分析結果や動脈硬化評価指数を、生体データと同様に表示用データ又は印刷用データに変換し、表示用データ又は印刷用データを表示部70又は記録部75に出力する。   In addition, the arithmetic control unit 10 performs waveform analysis such as feature point detection on the received or read biological data, or evaluates arteriosclerosis based on the result of the waveform analysis. (For example, ABI (Ankle Brachial Index), PWV (Pulse Wave Velocity), CAVI (Cardio-Ankle Vascular Index), etc.). The arithmetic control unit 10 converts the waveform analysis result and the arteriosclerosis evaluation index into display data or print data in the same manner as the biological data, and outputs the display data or print data to the display unit 70 or the recording unit 75. .

また、演算制御部10は、ユーザによる操作を支援するための音声ガイダンスが必要なときには、ガイダンス用データを音声発生部85に出力する。   Further, the arithmetic control unit 10 outputs guidance data to the voice generation unit 85 when voice guidance for assisting the user's operation is necessary.

表示部70は、例えばLCD(Liquid Crystal Display)等の表示装置であり、演算制御部10から入力された表示用データに従って、生体情報の測定結果、血管石灰化判定結果、波形分析結果及び動脈硬化評価指数を文字や波形等の視覚的な情報として画面に表示する。   The display unit 70 is a display device such as an LCD (Liquid Crystal Display), for example, and in accordance with display data input from the arithmetic control unit 10, measurement results of biological information, vascular calcification determination results, waveform analysis results, and arteriosclerosis The evaluation index is displayed on the screen as visual information such as characters and waveforms.

記録部75は、プリンタであり、演算制御部10から入力された印刷用データに従って、生体情報の測定結果、血管石灰化判定結果、波形分析結果及び動脈硬化評価指数を文字や波形等の視覚的な情報として用紙に印刷する。   The recording unit 75 is a printer, and in accordance with the printing data input from the arithmetic control unit 10, the measurement result of biological information, the vascular calcification determination result, the waveform analysis result, and the arteriosclerosis evaluation index are visually displayed as characters or waveforms Print on paper as useful information.

保存部80は、記憶装置であり、演算制御部10から入力される生体データの保持が可能である。   The storage unit 80 is a storage device and can hold biometric data input from the arithmetic control unit 10.

音声発生部85は、スピーカであり、演算制御部10から入力されたガイダンス用データに従って、ガイダンス音声を出力する。   The sound generation unit 85 is a speaker, and outputs a guidance sound according to the guidance data input from the arithmetic control unit 10.

操作部90は、キーボードやマウス、ボタン、タッチパネル等の入力装置であり、ユーザ(検査者)の操作に従って、計測動作や表示・印刷動作が実行されるよう入力信号を生成して演算制御部10に出力する。   The operation unit 90 is an input device such as a keyboard, a mouse, a button, or a touch panel. The operation unit 90 generates an input signal so that a measurement operation or a display / printing operation is executed according to a user (inspector) operation, and the arithmetic control unit 10. Output to.

脈波計測部50は、増幅器、フィルタ及びA/D(アナログディジタル)変換器(いずれも図示せず)を有しており、被検者の例えば頸動脈部及び股動脈部にそれぞれ装着されたアモルファス式の脈波センサ51a、51bによる検出信号に対し、増幅、高域雑音除去及びA/D変換といった信号処理を施し、信号処理後のディジタルデータを脈波データとして演算制御部10に供給する。脈波計測部50による脈波の計測は、演算制御部10で大動脈PWVを求める場合に好適に用いられる。   The pulse wave measurement unit 50 includes an amplifier, a filter, and an A / D (analog / digital) converter (none of which are shown), and is attached to, for example, a carotid artery portion and a hip artery portion of a subject. The detection signals from the amorphous pulse wave sensors 51a and 51b are subjected to signal processing such as amplification, high-frequency noise removal, and A / D conversion, and the digital data after the signal processing is supplied to the arithmetic control unit 10 as pulse wave data. . The pulse wave measurement by the pulse wave measurement unit 50 is preferably used when the calculation control unit 10 obtains the aorta PWV.

心電図計測部40は、増幅器、フィルタ及びA/D(アナログディジタル)変換器(いずれも図示せず)を有しており、被検者の四肢及び胸部にそれぞれ装着された心電電極部41a、41bによる検出信号に対し、増幅、高域雑音除去及びA/D変換といった信号処理を施し、信号処理後のディジタルデータを心電図データとして演算制御部10に供給する。   The electrocardiogram measurement unit 40 includes an amplifier, a filter, and an A / D (analog / digital) converter (none of which are shown), and an electrocardiogram electrode unit 41a attached to the limb and chest of the subject, The detection signal by 41b is subjected to signal processing such as amplification, high-frequency noise removal, and A / D conversion, and the digital data after the signal processing is supplied to the arithmetic control unit 10 as electrocardiogram data.

心音計測部30は、増幅器、フィルタ及びA/D(アナログディジタル)変換器(いずれも図示せず)を有しており、被検者の例えば心尖部に装着された心音マイク31による検出信号に対し、増幅、高域雑音除去及びA/D変換といった信号処理を施し、信号処理後のディジタルデータを心音データとして演算制御部10に供給する。   The heart sound measuring unit 30 includes an amplifier, a filter, and an A / D (analog / digital) converter (none of which is shown), and detects a detection signal from a heart sound microphone 31 attached to, for example, the apex of the subject. On the other hand, signal processing such as amplification, high-frequency noise removal, and A / D conversion is performed, and the digital data after the signal processing is supplied to the arithmetic control unit 10 as heart sound data.

測定部及び判定部としての血圧脈波計測部20は、増幅器、フィルタ及びA/D(アナログディジタル)変換器(いずれも図示せず)を有しており、被検者の左腕、右腕、左脚及び右脚にそれぞれ装着されたカフ21a〜21dによる検出信号に対し、増幅、高域雑音除去及びA/D変換といった信号処理を施すことにより、カフ圧データを得る。血圧脈波計測部20は、ポンプ24a〜24dと、排気弁25a〜25dと、圧力センサ26a〜26dと、導管27a〜27dと、ポンプ24a〜24d及び排気弁25a〜25dの制御のプログラム並びに血圧判定処理のプログラムを実行する演算処理装置(図示せず)と、これらのプログラムを記憶する記憶装置(図示せず)とをさらに有しており、カフ圧データを得る際には、ポンプ24a〜24dと排気弁25a〜25dとを制御する。ここで、カフ21a〜21dによる検出信号とは、カフ21a〜21dの空気袋211a〜211dの内部の空気圧を示す信号であって、圧力センサ26a〜26dにより検出されたものである。血圧脈波計測部20は、脈波計測の場合には、例えば左腕又は右腕のカフ圧データを脈波データとして演算制御部10に供給し、血圧計測の場合には、四肢それぞれのカフ圧データに対して血圧判定を行い、その結果を血圧データとして演算制御部10に供給する。血圧脈波計測部20は、血圧判定を行う際に血管石灰化判定も行う。この判定により血管石灰化の発症が認められた場合、血圧脈波計測部20は、血管石灰化の程度を表す石灰化指数を算出し、これを示す血管石灰化判定データを血圧データと共に演算制御部10に供給する。血管石灰化判定については後でより具体的に説明する。   The blood pressure pulse wave measurement unit 20 as a measurement unit and a determination unit includes an amplifier, a filter, and an A / D (analog / digital) converter (none of which are shown), and the left arm, right arm, and left of the subject. Cuff pressure data is obtained by performing signal processing such as amplification, high-frequency noise removal, and A / D conversion on detection signals from the cuffs 21a to 21d attached to the leg and the right leg, respectively. The blood pressure pulse wave measurement unit 20 includes a pump 24a to 24d, exhaust valves 25a to 25d, pressure sensors 26a to 26d, conduits 27a to 27d, control programs for the pumps 24a to 24d and exhaust valves 25a to 25d, and blood pressure. An arithmetic processing device (not shown) for executing a program for determination processing and a storage device (not shown) for storing these programs are further included. When obtaining cuff pressure data, the pumps 24a to 24 24d and the exhaust valves 25a to 25d are controlled. Here, the detection signals by the cuffs 21a to 21d are signals indicating the air pressure inside the air bags 211a to 211d of the cuffs 21a to 21d, and are detected by the pressure sensors 26a to 26d. In the case of pulse wave measurement, the blood pressure pulse wave measurement unit 20 supplies, for example, left arm or right arm cuff pressure data to the arithmetic control unit 10 as pulse wave data, and in the case of blood pressure measurement, cuff pressure data of each limb. The blood pressure is determined for the blood pressure, and the result is supplied to the arithmetic control unit 10 as blood pressure data. The blood pressure pulse wave measurement unit 20 also performs vascular calcification determination when performing blood pressure determination. When the onset of vascular calcification is recognized by this determination, the blood pressure pulse wave measurement unit 20 calculates a calcification index representing the degree of vascular calcification, and controls the vascular calcification determination data indicating this together with the blood pressure data. Supplied to the unit 10. The vascular calcification determination will be described more specifically later.

ポンプ24aは、流体連通された導管27a及びホース22aを介してカフ21aの空気袋211aの内部への給気を、血圧脈波計測部20の制御に従って行うことにより、カフ圧(つまり、空気袋211aの内部の空気圧)を加圧する。ポンプ24b〜24dの構成はポンプ24aと同様である。   The pump 24a supplies air to the inside of the air bag 211a of the cuff 21a via the conduit 27a and the hose 22a that are in fluid communication, according to the control of the blood pressure pulse wave measurement unit 20, and thereby the cuff pressure (that is, the air bag). The air pressure inside 211a is increased. The configuration of the pumps 24b to 24d is the same as that of the pump 24a.

排気弁25aは、例えば電磁式の弁であり、導管27aに設けられている。排気弁25aの開度は血圧脈波計測部20の制御に従って調整され、排気弁25aは、閉弁時には空気袋211a内の空気の排気を防止し、開弁時には空気袋211a内の空気を排気する。排気弁25b〜25dの構成は排気弁25aと同様である。   The exhaust valve 25a is, for example, an electromagnetic valve, and is provided in the conduit 27a. The opening degree of the exhaust valve 25a is adjusted according to the control of the blood pressure pulse wave measurement unit 20, and the exhaust valve 25a prevents the air in the air bag 211a from being exhausted when the valve is closed, and exhausts the air in the air bag 211a when the valve is opened. To do. The configuration of the exhaust valves 25b to 25d is the same as that of the exhaust valve 25a.

以下、血管石灰化判定の動作について図2を参照して説明する。ここでは、カフ21cを被検者の左脚に巻着固定し、左脚について血圧判定及び血管石灰化判定を行う場合を例にとって説明する。   Hereinafter, the blood vessel calcification determination operation will be described with reference to FIG. Here, a case where the cuff 21c is wound around and fixed to the left leg of the subject and blood pressure determination and vascular calcification determination are performed on the left leg will be described as an example.

まず、ステップS10では、血圧脈波計測部20で、一次血圧測定を実行する。一次血圧測定は、排気弁25cが完全に閉止されポンプ24cが作動されることにより空気袋211cへの給気が行われるとき、すなわちカフ加圧時に行われる。一次血圧測定においては、カフ加圧中に脈波の振幅が最大となる時のカフ21cのカフ圧が左脚の平均血圧の測定値MBPとして取得され、脈波の振幅が最大振幅まで増大する過程で急増した時のカフ21cのカフ圧が左脚の最低血圧の測定値SBPとして取得され、脈波の振幅が最大振幅から減少する過程で急減した時のカフ21cのカフ圧が左脚の最高血圧の測定値DBPとして取得される。カフ加圧は、カフ圧が予め設定された値まで上昇すると停止される。なお、カフ加圧の停止は、最高血圧の測定値の取得をトリガとして実行されてもよい。 First, in step S10, the blood pressure pulse wave measurement unit 20 performs primary blood pressure measurement. The primary blood pressure measurement is performed when the air supply to the air bladder 211c is performed by completely closing the exhaust valve 25c and operating the pump 24c, that is, at the time of cuff pressurization. In the primary blood pressure measurement, the cuff pressure of the cuff 21c when the amplitude of the pulse wave becomes maximum during cuff pressurization is acquired as the measurement value MBP 1 of the average blood pressure of the left leg, and the amplitude of the pulse wave increases to the maximum amplitude. The cuff pressure of the cuff 21c when rapidly increasing in the process is acquired as a measured value SBP 1 of the minimum blood pressure of the left leg, and the cuff pressure of the cuff 21c when rapidly decreasing in the process of decreasing the amplitude of the pulse wave from the maximum amplitude is left Acquired as a measured value DBP 1 of the systolic blood pressure of the leg. The cuff pressurization is stopped when the cuff pressure rises to a preset value. The cuff pressurization may be stopped by using the measurement value of the maximum blood pressure as a trigger.

ステップS10での一次血圧測定終了後、ステップS20では、血圧脈波計測部20で、二次血圧測定を実行する。二次血圧測定は、排気弁25cを非全開状態に開く制御を行うことにより空気袋211cからの排気が行われるとき、すなわちカフ減圧時に行われる。二次血圧測定においては、カフ減圧中に脈波の振幅が最大となる時のカフ21cのカフ圧が左脚の平均血圧の測定値MBPとして取得され、脈波の振幅が最大振幅まで増大する過程で急増した時のカフ21cのカフ圧が左脚の最高血圧の測定値DBPとして取得され、脈波の振幅が最大振幅から減少する過程で急減した時のカフ21cのカフ圧が左脚の最低血圧の測定値SBPとして取得される。カフ減圧は、カフ圧が予め設定された値まで低下すると停止される。なお、カフ減圧の停止は、最低血圧の測定値の取得をトリガとして実行されてもよい。 After completing the primary blood pressure measurement in step S10, in step S20, the blood pressure pulse wave measurement unit 20 performs secondary blood pressure measurement. The secondary blood pressure measurement is performed when exhaust from the air bag 211c is performed by performing control to open the exhaust valve 25c to a non-fully opened state, that is, when the cuff is decompressed. In the secondary blood pressure measurement, the cuff pressure of the cuff 21c at the time when the amplitude of the pulse wave becomes maximum during the cuff decompression is acquired as the measurement value MBP 2 of the average blood pressure of the left leg, and the amplitude of the pulse wave increases to the maximum amplitude. The cuff pressure of the cuff 21c at the time of sudden increase in the process is acquired as the measurement value DBP 2 of the maximum blood pressure of the left leg, and the cuff pressure of the cuff 21c at the time of sudden decrease in the process of decreasing the amplitude of the pulse wave from the maximum amplitude is Acquired as a measured value SBP 2 of the minimum blood pressure of the leg. The cuff pressure reduction is stopped when the cuff pressure drops to a preset value. The stop of the cuff decompression may be executed with the acquisition of the measured value of the minimum blood pressure as a trigger.

ここで、一次血圧測定(つまり、カフ加圧中の血圧測定)の結果の例を図3(b)及び図4(b)に、また、二次血圧測定(つまり、カフ減圧中の血圧測定)の結果の例を、図3(a)及び図4(a)に、それぞれ示す。これらの例に示すように、カフ加圧時とカフ減圧時とでは、脈波振幅の変動の態様が同一とならない。また、この非同一性は、血管の石灰化による硬化が進行するほど顕著となる。本発明者は、このようなカフ加圧時とカフ減圧時とにおける脈波振幅の変動態様の非同一性に着目した結果として、本願発明に至ったものである。図3及び図4に示す例を用いた血圧石灰化判定については後で詳述する。   Here, examples of the results of primary blood pressure measurement (that is, blood pressure measurement during cuff pressurization) are shown in FIGS. 3B and 4B, and secondary blood pressure measurement (that is, blood pressure measurement during cuff decompression). ) Shows an example of the results of FIG. 3 (a) and FIG. 4 (a), respectively. As shown in these examples, the variation of the pulse wave amplitude is not the same between the cuff pressurization and the cuff decompression. Moreover, this non-identity becomes so remarkable that hardening by the calcification of the blood vessel progresses. The present inventor has arrived at the present invention as a result of paying attention to the non-identity of the fluctuation mode of the pulse wave amplitude between the cuff pressurization and the cuff decompression. The blood pressure calcification determination using the example shown in FIGS. 3 and 4 will be described in detail later.

ステップS20での二次血圧測定終了後、ステップS30では、血圧脈波計測部20で、最低血圧の測定値SBP、SBPの差dを算出する。 After the completion of the secondary blood pressure measurement in step S20, in step S30, the blood pressure pulse wave measurement unit 20 calculates the difference d between the measured values SBP 1 and SBP 2 of the minimum blood pressure.

そして、ステップS40では、血圧脈波計測部20で、例えば算出した差dを所定値と比較することにより、血管石灰化の発症の可能性を判定する。算出した差dが所定値以上である場合、つまり最低血圧の測定値SBP、SBPに顕著な差がある場合は、被検者の左脚に血管石灰化が発症している可能性があると判定する。算出した差dが所定値未満である場合、つまり最低血圧の測定値SBP、SBPに顕著な差がない場合は、被検者の左脚に血管石灰化が発症している可能性はないと判定する。 In step S40, the blood pressure pulse wave measurement unit 20 determines, for example, the possibility of the onset of vascular calcification by comparing the calculated difference d with a predetermined value. If the calculated difference d is greater than or equal to a predetermined value, that is, if there is a significant difference between the measured values SBP 1 and SBP 2 of the minimum blood pressure, there is a possibility that vascular calcification has developed in the left leg of the subject. Judge that there is. When the calculated difference d is less than a predetermined value, that is, when there is no significant difference between the measured values SBP 1 and SBP 2 of the minimum blood pressure, there is a possibility that vascular calcification has developed in the left leg of the subject. Judge that there is no.

血管石灰化の可能性ありと判定された場合は、ステップS50に進み、血圧脈波計測部20で、測定値SBP、SBPの差dから石灰化指数CSを算出する。 When it is determined that there is a possibility of blood vessel calcification, the process proceeds to step S50, and the blood pressure pulse wave measurement unit 20 calculates the calcification index CS from the difference d between the measured values SBP 1 and SBP 2 .

そして、ステップS60では、血圧脈波計測部20で、例えば測定値SBP、SBPとその差dとを所定の数式に代入することにより、最低血圧の判定値SBPを、測定値SBP、SBPの補正値として算出する。このようにして得られた最低血圧の判定値SBP、換言すれば補正された最低血圧の測定値は、血圧判定の結果として血圧データに示され、血圧脈波計測部20から演算制御部10に供給される。また、この血圧データと共に、石灰化指数CSを示す血管石灰化判定データも、血圧脈波計測部20から演算制御部10に供給される。 In step S60, the blood pressure pulse wave measurement unit 20 substitutes, for example, the measured values SBP 1 and SBP 2 and the difference d thereof into a predetermined mathematical formula to obtain the determination value SBP of the minimum blood pressure as the measured value SBP 1 , Calculated as the SBP 2 correction value. The diastolic blood pressure determination value SBP obtained in this manner, in other words, the corrected diastolic blood pressure measurement value is indicated in the blood pressure data as a result of blood pressure determination, and is sent from the blood pressure pulse wave measurement unit 20 to the arithmetic control unit 10. Supplied. In addition to the blood pressure data, blood vessel calcification determination data indicating the calcification index CS is also supplied from the blood pressure pulse wave measurement unit 20 to the arithmetic control unit 10.

そして、ステップS70では、演算制御部10で、血管石灰化判定データを表示用データに変換し、表示用データを表示部70に出力することにより、表示部70に、石灰化指数CSと、血管石灰化の可能性がある旨の血管石灰化警告とを、表示させる。   In step S70, the arithmetic and control unit 10 converts the blood vessel calcification determination data into display data and outputs the display data to the display unit 70, whereby the display unit 70 has the calcification index CS and the blood vessel. A vascular calcification warning indicating the possibility of calcification is displayed.

血管石灰化の可能性なしと判定された場合は、ステップS80に進み、血圧脈波計測部20で、測定値SBP、SBPのいずれか一方又は測定値SBP、SBPの平均値を最低血圧の判定値SBPとする。このようにして得られた最低血圧の判定値SBPは、血圧判定の結果として血圧データに示され、血圧脈波計測部20から演算制御部10に供給される。ただし、血管石灰化判定データの供給は行われない。よって、石灰化指数や血管石灰化警告の表示も行われない。 When it is determined that there is no possibility of blood vessel calcification, the process proceeds to step S80, and the blood pressure pulse wave measurement unit 20 calculates one of the measurement values SBP 1 and SBP 2 or the average value of the measurement values SBP 1 and SBP 2. The determination value SBP for the minimum blood pressure is used. The determination value SBP of the minimum blood pressure obtained in this way is indicated in the blood pressure data as a result of blood pressure determination, and is supplied from the blood pressure pulse wave measurement unit 20 to the arithmetic control unit 10. However, supply of blood vessel calcification determination data is not performed. Therefore, neither a calcification index nor a blood vessel calcification warning is displayed.

以上のようにして、血管石灰化判定が行われる。   The blood vessel calcification determination is performed as described above.

なお、上記の例では、最低血圧の測定値SBP、SBPの差を算出したが、その代わりに、平均血圧の測定値MBP、MBPの差を算出し、その算出結果に基づいて血管石灰化判定を行ってもよく、最高血圧の測定値DBP、DBPの差を算出し、その算出結果に基づいて血管石灰化判定を行ってもよい。或いは、最低血圧の測定値SBP、SBPの差と平均血圧の測定値MBP、MBPの差と最高血圧の測定値DBP、DBPの差とのうち複数のものを算出し、これらの算出結果に基づいて血管石灰化判定を行ってもよい。最低血圧や平均血圧、最高血圧と異なる血圧の測定値を使用することも可能である。 In the above example, the difference between the measured values SBP 1 and SBP 2 of the minimum blood pressure is calculated, but instead, the difference between the measured values MBP 1 and MBP 2 of the average blood pressure is calculated, and based on the calculation result Blood vessel calcification determination may be performed, or the difference between the measured values DBP 1 and DBP 2 of the systolic blood pressure may be calculated, and blood vessel calcification determination may be performed based on the calculation result. Alternatively, a plurality of the difference between the measured values SBP 1 and SBP 2 of the minimum blood pressure and the measured values MBP 1 and MBP 2 of the average blood pressure and the measured values DBP 1 and DBP 2 of the maximum blood pressure are calculated, Blood vessel calcification determination may be performed based on these calculation results. It is also possible to use measured values of blood pressure different from the minimum blood pressure, the average blood pressure and the maximum blood pressure.

また、上記の例では、左脚について血管石灰化判定を行ったが、右脚、左腕、右腕についても同様に血管石灰化判定を行うことができる。したがって、血管石灰化判定は、一箇所についてのみ行うことも、複数箇所について行うこともできる。   In the above example, the vascular calcification determination is performed for the left leg. However, the vascular calcification determination can be performed similarly for the right leg, the left arm, and the right arm. Therefore, the blood vessel calcification determination can be performed only for one place or for a plurality of places.

また、上記の例では、血管石灰化の可能性がある旨の情報として、血管石灰化警告及び石灰化指数の両方を表示させたが、血管石灰化警告及び石灰化指数のうち一方のみを表示させてもよい。   In the above example, both the vascular calcification warning and the calcification index are displayed as information indicating the possibility of vascular calcification, but only one of the vascular calcification warning and the calcification index is displayed. You may let them.

また、上記の例では、血管石灰化の可能性の判定結果に応じて血管石灰化警告及び石灰化指数の表示/非表示を切り替える一方で、血圧の判定結果は常に非表示であるが、血圧の判定結果を常に表示させるようにしてもよい。   In the above example, the blood vessel calcification warning and the calcification index display / non-display are switched according to the determination result of the possibility of vascular calcification, while the blood pressure determination result is always hidden. The determination result may be always displayed.

また、上記の例では、血管石灰化の可能性なしと判定された場合には、血管石灰化判定結果について何ら表示させていないが、血管石灰化の可能性がない旨の情報を表示させてもよい。   In the above example, if it is determined that there is no possibility of vascular calcification, no information is displayed on the determination result of vascular calcification, but information indicating that there is no possibility of vascular calcification is displayed. Also good.

また、上記の例では、血管石灰化警告及び石灰化指数を表示させたが、血管石灰化警告及び石灰化指数を印刷させるようにしてもよい。   In the above example, the vascular calcification warning and the calcification index are displayed. However, the vascular calcification warning and the calcification index may be printed.

次いで、図3及び図4に示す血圧測定結果の例を比較して、血管石灰化判定について説明する。   Next, blood vessel calcification determination will be described by comparing the blood pressure measurement results shown in FIGS. 3 and 4.

図3は、ある被検者についての血圧測定結果を、図4は、別の被検者についての血圧測定結果を、それぞれ示した図である。図3(a)及び図4(a)は、カフ減圧中の測定結果を示すものであり、したがって血圧の測定値は矢印P、Pの方向に変動する。図3(b)及び図4(b)は、カフ加圧中の測定結果を示すものであり、したがって血圧の測定値は矢印P、Pの方向に変動する。 FIG. 3 is a view showing a blood pressure measurement result for a subject, and FIG. 4 is a view showing a blood pressure measurement result for another subject. FIG. 3A and FIG. 4A show the measurement results during cuff decompression, and thus the measured values of blood pressure fluctuate in the directions of arrows P 1 and P 3 . FIG. 3B and FIG. 4B show the measurement results during cuff pressurization, and thus the blood pressure measurement values fluctuate in the directions of arrows P 2 and P 4 .

まず、図3を参照すると、図3(a)におけるA部分は、カフ減圧中に脈波の振幅が最大となる部分を示し、図3(b)におけるB部分は、カフ加圧中に脈波の振幅が最大となる部分を示す。A部分の振幅に対応する血圧測定値(つまり減圧中の平均血圧の測定値)と、B部分の振幅に対応する血圧測定値(つまり加圧中の平均血圧の測定値)との差dABは約20mmHgであり、比較的大きく、顕著なものとなっている。 First, referring to FIG. 3, an A portion in FIG. 3 (a) shows a portion where the amplitude of the pulse wave becomes maximum during cuff decompression, and a B portion in FIG. 3 (b) shows a pulse during cuff pressurization. The part where the amplitude of the wave is maximum is shown. Difference between the blood pressure measurement value corresponding to the amplitude of the A portion (that is, the measurement value of the average blood pressure during decompression) and the blood pressure measurement value corresponding to the amplitude of the B portion (that is, the measurement value of the average blood pressure during pressurization) d AB Is about 20 mmHg, which is relatively large and remarkable.

また、図3(a)におけるC部分は、カフ減圧中に脈波の振幅が最大振幅の約50%となる部分を示し、図3(b)におけるD部分は、カフ加圧中に脈波の振幅が最大振幅の約50%となる部分を示す。C部分の振幅に対応する血圧測定値(つまり減圧中の最低血圧の測定値)と、D部分の振幅に対応する血圧測定値(つまり加圧中の最低血圧の測定値)との差dCDは約20mmHgであり、上記の差dABと同様に比較的大きく、顕著なものとなっている。 3A shows a portion where the amplitude of the pulse wave is about 50% of the maximum amplitude during cuff decompression, and D portion in FIG. 3B shows the pulse wave during cuff pressurization. Indicates a portion where the amplitude of is about 50% of the maximum amplitude. The difference d CD between the blood pressure measurement value corresponding to the amplitude of the C portion (that is, the measurement value of the minimum blood pressure during decompression) and the blood pressure measurement value corresponding to the amplitude of the D portion (that is, the measurement value of the minimum blood pressure during pressurization) Is about 20 mmHg, which is relatively large and remarkable, similar to the difference d AB described above.

一方、図4を参照すると、図4(a)におけるE部分は、カフ減圧中に脈波の振幅が最大となる部分を示し、図4(b)におけるF部分は、カフ加圧中に脈波の振幅が最大となる部分を示す。E部分の振幅に対応する血圧測定値(つまり減圧中の平均血圧の測定値)と、F部分の振幅に対応する血圧測定値(つまり加圧中の平均血圧の測定値)との差dEFは約5mmHgであり、比較的小さいものとなっている。 On the other hand, referring to FIG. 4, an E portion in FIG. 4 (a) shows a portion where the amplitude of the pulse wave becomes maximum during cuff decompression, and an F portion in FIG. 4 (b) shows a pulse during cuff pressurization. The part where the amplitude of the wave is maximum is shown. The difference between the blood pressure measurement value corresponding to the amplitude of the E portion (that is, the measurement value of the average blood pressure during decompression) and the blood pressure measurement value corresponding to the amplitude of the F portion (that is, the measurement value of the average blood pressure during pressurization) d EF Is about 5 mmHg, which is relatively small.

また、図4(a)におけるG部分は、カフ減圧中に脈波の振幅が最大振幅の約50%となる部分を示し、図4(b)におけるH部分は、カフ加圧中に脈波の振幅が最大振幅の約50%となる部分を示す。G部分の振幅に対応する血圧測定値(つまり減圧中の最低血圧の測定値)と、H部分の振幅に対応する血圧測定値(つまり加圧中の最低血圧の測定値)との差dGHは約10mmHgであり、上記の差dEFと同様に比較的小さいものとなっている。 4A shows a portion where the amplitude of the pulse wave is about 50% of the maximum amplitude during cuff decompression, and the H portion in FIG. 4B shows the pulse wave during cuff pressurization. Indicates a portion where the amplitude of is about 50% of the maximum amplitude. The difference d GH between the blood pressure measurement value corresponding to the amplitude of the G portion (ie, the measurement value of the minimum blood pressure during decompression) and the blood pressure measurement value corresponding to the amplitude of the H portion (ie, the measurement value of the minimum blood pressure during pressurization) Is about 10 mmHg, which is relatively small like the difference d EF described above.

したがって、図3に示された血圧測定結果に対して血管石灰化判定を行うと血管石灰化の可能性ありと判定することができる一方、図4に示された血圧測定結果に対して血管石灰化判定を行うと血管石灰化の可能性なしと判定することができる。   Therefore, when blood vessel calcification determination is performed on the blood pressure measurement result shown in FIG. 3, it can be determined that there is a possibility of blood vessel calcification, while blood vessel calcification is performed on the blood pressure measurement result shown in FIG. It is possible to determine that there is no possibility of vascular calcification when the determination is made.

このように、本実施の形態によれば、血圧の判定の際に血管石灰化の判定も行い、血管石灰化の可能性があると判定した場合には、それに応じた内容を表示するため、血管石灰化の発症者に対しても血圧脈波検査装置を好適に使用することができる。   Thus, according to the present embodiment, blood vessel calcification is also determined at the time of blood pressure determination, and when it is determined that there is a possibility of blood vessel calcification, the content corresponding to that is displayed. The blood pressure pulse wave inspection apparatus can be suitably used for those who develop vascular calcification.

以上、本発明の実施の形態について説明した。なお、以上の説明は本発明の好適な実施の形態の例証であり、本発明の範囲はこれに限定されない。つまり、上記装置の構成についての説明は一例であり、本発明の範囲においてこれらの例に対する様々な変更や追加が可能であることは明らかである。例えば、本発明は、血圧脈波検査装置だけでなく電子血圧計等、様々な生体情報測定装置に適用して実施することが可能である。   The embodiment of the present invention has been described above. The above description is an illustration of a preferred embodiment of the present invention, and the scope of the present invention is not limited to this. That is, the description of the configuration of the above apparatus is an example, and it is obvious that various modifications and additions to these examples are possible within the scope of the present invention. For example, the present invention can be applied to various biological information measuring devices such as an electronic blood pressure monitor as well as a blood pressure pulse wave inspection device.

本発明の一実施の形態に係る血圧脈波検査装置の構成を示す図The figure which shows the structure of the blood pressure pulse wave test | inspection apparatus which concerns on one embodiment of this invention. 本発明の一実施の形態に係る血管石灰化判定動作を説明するためのフロー図The flowchart for demonstrating the blood vessel calcification determination operation | movement which concerns on one embodiment of this invention. 血圧測定結果の一例を示す図Figure showing an example of blood pressure measurement results 血圧測定結果の他の例を示す図The figure which shows the other example of the blood pressure measurement result

符号の説明Explanation of symbols

10 演算制御部
20 血圧脈波計測部
21a、21b、21c、21d カフ
24a、24b、24c、24d ポンプ
25a、25b、25c、25d 排気弁
26a、26b、26c、26d 圧力センサ
70 表示部
211a、211b、211c、211d 空気袋
10 Calculation control unit 20 Blood pressure pulse wave measurement unit 21a, 21b, 21c, 21d Cuff 24a, 24b, 24c, 24d Pump 25a, 25b, 25c, 25d Exhaust valve 26a, 26b, 26c, 26d Pressure sensor 70 Display unit 211a, 211b 211c, 211d Air bag

Claims (4)

カフ圧の加圧中及び減圧中に血圧を測定する測定部と、
前記カフ圧の加圧中及び減圧中に測定した前記血圧の値の差を判定する判定部と、
判定の結果、前記差がある場合に、血管石灰化の可能性がある旨の情報を表示する表示部と、
を有することを特徴とする生体情報測定装置。
A measurement unit for measuring blood pressure during cuff pressure pressurization and decompression;
A determination unit for determining a difference between values of the blood pressure measured during pressurization and decompression of the cuff pressure;
As a result of the determination, if there is the difference, a display unit that displays information that there is a possibility of vascular calcification;
A biological information measuring device comprising:
前記測定部は、平均血圧、最低血圧又は最高血圧を測定し、
前記判定部は、測定した前記平均血圧、前記最低血圧又は前記最高血圧の値の差を判定する、
ことを特徴とする請求項1記載の生体情報測定装置。
The measurement unit measures average blood pressure, diastolic blood pressure or systolic blood pressure,
The determination unit determines a difference between the measured average blood pressure, the minimum blood pressure, or the maximum blood pressure;
The biological information measuring apparatus according to claim 1.
前記判定部は、判定した前記差に基づいて血管石灰化の程度を判定し、
前記表示部は、判定した前記血管石灰化の程度を示す情報を表示する、
ことを特徴とする請求項1記載の生体情報測定装置。
The determination unit determines the degree of vascular calcification based on the determined difference,
The display unit displays information indicating the determined degree of vascular calcification,
The biological information measuring apparatus according to claim 1.
前記判定部は、判定した前記差に基づいて、測定した前記血圧の値を補正し、
前記表示部は、補正した前記血圧の値を表示する、
ことを特徴とする請求項1記載の生体情報測定装置。
The determination unit corrects the measured blood pressure value based on the determined difference,
The display unit displays the corrected blood pressure value.
The biological information measuring apparatus according to claim 1.
JP2008081216A 2008-03-26 2008-03-26 Biological information measuring device Active JP5095463B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008081216A JP5095463B2 (en) 2008-03-26 2008-03-26 Biological information measuring device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008081216A JP5095463B2 (en) 2008-03-26 2008-03-26 Biological information measuring device

Publications (2)

Publication Number Publication Date
JP2009233003A JP2009233003A (en) 2009-10-15
JP5095463B2 true JP5095463B2 (en) 2012-12-12

Family

ID=41247714

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008081216A Active JP5095463B2 (en) 2008-03-26 2008-03-26 Biological information measuring device

Country Status (1)

Country Link
JP (1) JP5095463B2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012200507A (en) 2011-03-28 2012-10-22 Omron Healthcare Co Ltd Electronic sphygmomanometer and calculation program
JP6658332B2 (en) * 2016-06-23 2020-03-04 オムロンヘルスケア株式会社 Sphygmomanometer
TWI790479B (en) * 2020-09-17 2023-01-21 宏碁股份有限公司 Physiological status evaluation method and physiological status evaluation device

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001017401A (en) * 1999-07-08 2001-01-23 Nippon Colin Co Ltd Blood pressure measuring device with body fat factor measuring function
JP3568515B2 (en) * 2001-12-06 2004-09-22 コーリンメディカルテクノロジー株式会社 Lower limb upper limb blood pressure index measurement device

Also Published As

Publication number Publication date
JP2009233003A (en) 2009-10-15

Similar Documents

Publication Publication Date Title
Alpert et al. Oscillometric blood pressure: a review for clinicians
JP6003487B2 (en) Blood pressure measuring device, blood pressure measuring method, blood pressure measuring program
JP3626171B1 (en) Cardiodynamic evaluation device
JP5644325B2 (en) Blood pressure information measuring device and method for calculating an index of arteriosclerosis in the device
US20110257539A1 (en) Electronic sphygmomanometer and blood pressure measurement method
Kumar et al. Past, present and future of blood pressure measuring instruments and their calibration
US20110152699A1 (en) Blood pressure measuring apparatus and method for measuring blood vessel elasticity
JP4289850B2 (en) Automatic indirect non-invasive device and method for determining diastolic blood pressure by calibrating vibration waveforms
JP3632021B2 (en) Automatic diagnostic equipment
US20110319771A1 (en) Vital luminal part evaluating apparatus
WO2013061765A9 (en) Measuring device, evaluation method, and evaluation program
JP5095463B2 (en) Biological information measuring device
US6669646B1 (en) Arteriosclerosis evaluating apparatus
JP5208150B2 (en) Electronic blood pressure monitor
JP2008018035A (en) Apparatus for measuring pulse wave propagation speed, method for calculating pulse wave propagation speed, program and machine readable recording medium having program recorded thereon
TWI692345B (en) A blood pressure measuring apparatus capable of estimating arteriosclerosis
JP5530073B2 (en) Blood pressure pulse wave inspection device
JP4730332B2 (en) Blood pressure measurement device and measurement data processing program
KR101283798B1 (en) Apparatus and method for automatic measurement of blood pressure values based on oscillometric method and korotkoff sounds method
JP5752162B2 (en) Blood pressure pulse wave inspection device
JP5616253B2 (en) Pulse wave analyzer
JP2022524186A (en) Blood pressure measurement system and blood pressure measurement method using it
JP5095464B2 (en) Biological information measuring device
JP3168025U (en) Blood pressure information measuring device
JP5006509B2 (en) Pulse wave velocity measurement method for measuring pulse wave velocity in a pulse wave velocity measuring device

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110127

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20120820

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120828

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120919

R150 Certificate of patent or registration of utility model

Ref document number: 5095463

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150928

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250